高血氨大鼠服用乳酸菌后焦虑降低和认知功能改善
查看参考文献52篇
文摘
|
相关证据表明, 高血氨(HA)引发的神经炎和五羟色胺(5-HT)系统异常可能是导致肝性脑病(HE)认知功能下降和焦虑症状的原因. 服用益生菌可能是治疗HE神经精神症状的有效措施, 因为益生菌在维护免疫系统平衡和调节5-HT 系统活动中发挥了重要的作用. 检验了益生菌瑞士乳杆菌NS8改善HA 大鼠认知功能下降和焦虑行为的有效性. 通过连续4周的腹腔注射醋酸铵造成Sprague-Dawley 大鼠的高血氨. 然后让HA大鼠每日饮用添加了瑞士乳杆菌NS8(10_9 CFU/mL)的饮水. Morris 水迷宫测试大鼠的认知功能, 高架十字测试大鼠的焦虑行为. 脑区神经炎的程度以炎性标记物诱导型一氧化氮合酶、前列腺素E2和白介素1β 的水平表示. 5-HT 系统的活动以5-HT,5-HIAA(5-HT 的代谢物)以及色氨酸(5-HT 的前体物质)的水平表示. 益生菌处理显著地降低了HA大鼠的神经炎程度, 减少了5-HT 系统的活动, 改善了认知功能和焦虑行为. 这些结果说明, 服用益生菌瑞士乳杆菌NS8是治疗HA 大鼠认知功能下降和焦虑的有效方法. |
来源
|
中国科学. 生命科学
,2014,44(2):208-217 【核心库】
|
关键词
|
高血氨
;
益生菌
;
认知
;
焦虑
;
神经炎
;
五羟色胺
|
地址
|
中国科学院心理研究所, 中国科学院心理健康重点实验室, 北京, 100101
|
语种
|
中文 |
文献类型
|
研究性论文 |
ISSN
|
1674-7232 |
基金
|
日本NSBJ 乳酸菌研究特别寄付金资助
|
文献收藏号
|
CSCD:5061161
|
参考文献 共
52
共3页
|
1.
Rodrigo R. Hyperammonemia induces neuroinflammation that contributes to cognitive impairment in rats with hepatic encephalopathy.
Gastroenterology,2010,139:675-684
|
CSCD被引
7
次
|
|
|
|
2.
Brusilow S W. Hyperammonemic encephalopathy.
Medicine,2002,81:240-249
|
CSCD被引
3
次
|
|
|
|
3.
Felipo V. Neurobiology of ammonia.
Prog Neurobiol,2002,67:259-279
|
CSCD被引
9
次
|
|
|
|
4.
Lajtha A.
Handbook of Neurochemistry and Molecular Neurobiology. 3rd ed,2008
|
CSCD被引
1
次
|
|
|
|
5.
Basile A S. Ammonia and GABA-ergic neurotransmission: interrelated factors in the pathogenesis of hepatic encephalopathy.
Hepatology,1997,25:1303-1305
|
CSCD被引
2
次
|
|
|
|
6.
Montoliu C. IL-6 and IL-18 in blood may discriminate cirrhotic patients with and without minimal hepatic encephalopathy.
J Clin Gastroenterol,2009,43:272-279
|
CSCD被引
2
次
|
|
|
|
7.
Gibertini M. Spatial learning impairment in mice infected with legionella pneumophila or administered exogenous interleukin-1-β.
Brain Behav Immun,1995,9:113-128
|
CSCD被引
1
次
|
|
|
|
8.
Wiltfang J. Psychiatric aspects of portal-systemic encephalopathy.
Metab Brain Dis,1998,13:379-389
|
CSCD被引
1
次
|
|
|
|
9.
Erecinska M. Ammonia-induced release of neurotransmitters from rat brain synaptosomes: differences between the effects on amines and amino acids.
J Neurochem,1987,49:1258-1265
|
CSCD被引
1
次
|
|
|
|
10.
Murphy D L. Anxiety and affective disorder comorbidity related to serotonin and other neurotransmitter systems: obsessive-compulsive disorder as an example of overlapping clinical and genetic heterogeneity.
Philos Trans R Soc B-Biol Sci,2013,368:20120435
|
CSCD被引
2
次
|
|
|
|
11.
Bergqvist P B F. Ammonium acetate challenge in experimental chronic hepatic encephalopathy induces a transient increase of brain 5-HT release in vivo.
Eur Neuropsychopharm,1996,6:317-322
|
CSCD被引
1
次
|
|
|
|
12.
Rossle M. Amino acid, ammonia and neurotransmitter concentrations in hepatic encephalopathy: serial analysis in plasma and cerebrospinal fluid during treatment with an adapted amino acid solution.
Klin Wochenschr,1984,62:867-875
|
CSCD被引
1
次
|
|
|
|
13.
Miura H. A link between stress and depression: shifts in the balance between the kynurenine and serotonin pathways of tryptophan metabolism and the etiology and pathophysiology of depression.
Stress,2008,11:198-209
|
CSCD被引
6
次
|
|
|
|
14.
Vignau J. Impact of interferon alpha immunotherapy on tryptophan metabolism in patients with chronic hepatitis C. Results of a pilot studies on ten patients (in French).
Encephale,2009,35:477-483
|
CSCD被引
1
次
|
|
|
|
15.
Laugeray A. Peripheral and cerebral metabolic abnormalities of the tryptophan-kynurenine pathway in a murine model of major depression.
Behav Brain Res,2010,210:84-91
|
CSCD被引
5
次
|
|
|
|
16.
Butterworth R F. Experimental models of hepatic encephalopathy: ISHEN guidelines.
Liver Int,2009,29:783-788
|
CSCD被引
7
次
|
|
|
|
17.
Lena P J. Effects of melatonin on the levels of antioxidants and lipid peroxidation products in rats treated with ammonium acetate.
Pharmazie,2004,59:636-639
|
CSCD被引
2
次
|
|
|
|
18.
Moroni F. The release and neosynthesis of glutamic acid are increased in experimental models of hepatic encephalopathy.
J Neurochem,1983,40:850-854
|
CSCD被引
1
次
|
|
|
|
19.
Subash S. Morin a flavonoid exerts antioxidant potential in chronic hyperammonemic rats: a biochemical and histopathological study.
Mol Cell Biochem,2009,327:153-161
|
CSCD被引
2
次
|
|
|
|
20.
Bajaj J S. Predictors of the recurrence of hepatic encephalopathy in lactulose-treated patients.
Aliment Pharmacol Ther,2010,31:1012-1017
|
CSCD被引
3
次
|
|
|
|
|